BFG
WST icon

Bleakley Financial Group’s West Pharmaceutical WST Stock Holding History

Bleakley Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,170
Closed -$711K – 1028
2024
Q4 		$711K Sell
2,170
-188
-8% -$59.2K 0.02% 512
2024
Q3 		$708K Buy
2,358
+76
+3% +$23.3K 0.02% 495
2024
Q2 		$752K Buy
2,282
+108
+5% +$38.2K 0.02% 485
2024
Q1 		$860K Buy
2,174
+41
+2% +$15.2K 0.02% 468
2023
Q4 		$751K Sell
2,133
-12
-0.6% -$4.25K 0.02% 479
2023
Q3 		$805K Sell
2,145
-55
-3% -$21.3K 0.03% 423
2023
Q2 		$841K Buy
2,200
+38
+2% +$13.6K 0.03% 448
2023
Q1 		$749K Sell
2,162
-105
-5% -$30.7K 0.03% 462
2022
Q4 		$534K Buy
+2,267
New +$537K 0.02% 537

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Bleakley Financial Group's WST Position: Q1 2025 in Review

Bleakley Financial Group sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 2,170 shares — an estimated $711K sold.

Bleakley Financial Group first reported a position in WST in Q4 2022 and held it in 9 quarters. The position peaked at $860K in Q1 2024. 713 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Bleakley Financial Group reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 2,170 West Pharmaceutical shares in Q1 2025, an estimated $711K.
  • Bleakley Financial Group first reported a position in West Pharmaceutical in Q4 2022 and held it in 9 quarters.
  • Bleakley Financial Group's West Pharmaceutical position peaked at $860K in Q1 2024.
  • 713 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.